Suppression of the phytohemagglutinin response to lymphocytes is an independent prognosticator in patients with squamous cell carcinoma of the esophagus

Annals of Thoracic Surgery

Volumn 76, Issue 1, 2003, Pages 260-265

  Nozoe, Tadahiro ^a   Korenaga, Daisuke ^b   Ohga, Takefumi ^b   Futatsugi, Motonori ^b   Maehara, Yoshihiko ^b  

^a FUKUOKA DENTAL COLLEGE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PHYTOHEMAGGLUTININ;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CONTROLLED STUDY; DISEASE ASSOCIATION; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; IMMUNE STATUS; LYMPH NODE METASTASIS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE TRANSFORMATION TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POOR GENERAL CONDITION; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; PHYTOHEMAGGLUTININS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROBABILITY; PROGNOSIS; RADIOTHERAPY, ADJUVANT; REGRESSION ANALYSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0038676346     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(03)00165-6     Document Type: Article

References (23)

1. Neuner A, Schindel M, Wildenberg U, Muley T, Lahm H, Fischer JR. Prognostic significance of cytokine modulation in non-small cell lung cancer. Int J Cancer 2002;101:287-92.
2. Takagi K, Yamamori H, Morishima Y, Toyoda Y, Nakajima N, Tashiro T. Preoperative immunosuppression: its relationship with high morbidity and mortality in patients receiving thoracic esophagectomy. Nutrition 2001;17:13-7.
3. Nozoe T, Saeki H, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. Am J Surg 2001;182:197-201.
4. Nozoe T, Kimura Y, Ishida M, et al. Correlation of preoperative nutritional condition with postoperative complications in surgical treatment for esophageal carcinoma. Eur J Surg Oncol 2002;28:396-400.
5. Tsutsui S, Sonoda K, Sumiyoshi K, et al. Prognostic significance of immunological parameters in patients with esophageal cancer. Hepatogastroenterology 1996;43:501-9.
6. Tsutsui S, Morita M, Kuwano H, et al. Influence of preoperative treatment and surgical operation on immune function of patients with esophageal carcinoma. J Surg Oncol 1992;49:176-81.
7. Zembala M, Mytar B, Ruggiero I, et al. Suppressor cells and survival of patients with advanced gastric cancer. J Natl Cancer Inst 1983;70:223-8.
8. Munemoto Y, Iida Y, Abe J, et al. Significance of postoperative adjuvant immunochemotherapy after curative resection of colorectal cancers: association between host or tumor factors and survival. Int J Oncol 2002;20:403-11.
9. Wiltschke C, Krainer M, Budinsky AC, et al. Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study. Br J Cancer 1995;71:1292-6.
10. Morita M, Kuwano H, Araki K, et al. Prognostic significance of lymphocyte infiltration following preoperative chemoradiotherapy and hyperthermia for esophageal cancer. Int J Radiat Oncol Biol Phys 2001;49:1259-66.
11. Japanese Society for Esophageal Diseases. Guidelines for the clinical and pathological studies on carcinoma of the esophagus, 9th ed. Tokyo: Kanehara Company, 1999.
12. LH Sobin, Wittekind C, ed. International Union Against Cancer. TNM classification of malignant tumors, 5th ed. New York: Wiley-Liss, 1997:54-8.
13. Avendano CE, Flume PA, Silvestri GA, King LB, Reed CE. Pulmonary complications after esophagectomy. Ann Thorac Surg 2002;73:922-6.
14. Kinugasa S, Tachibana M, Yoshimura H, et al. Esophageal resection in elderly esophageal carcinoma patients: improvement in postoperative complications. Ann Thorac Surg 2001;71:414-8.
15. Nozoe T, Matsumata T, Kitamura M, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg 1998;176:335-8.
16. Nozoe T, Matsumata T, Sugimachi K. Preoperative elevation of serum C-reactive protein is related to impaired immunity in patients with colorectal cancer. Am J Clin Oncol 2000;23:263-6.
17. Nozoe T, Anai H, Sugimachi K. Usefulness of reconstruction with jejunal pouch in total gastrectomy for gastric cancer in early improvement of nutritional condition. Am J Surg 2001;181:274-8.
18. Buzby GP, Mullen JL, Matthews DC, et al. Prognostic nutritional index in gastrointestinal surgery. Am J Surg 1980;139:160-7.
19. Bentdal OH, Froland SS, Bosnes V, et al. Alterations in lymphocyte subsets in blood may predict resectability in carcinoma of cardia or oesophagus. Cancer Lett 1996;100:133-8.
20. Saito T, Shimoda K, Shigemitsu Y, et al. Complications of infection and immunologic status after surgery for patients with esophageal cancer. J Surg Oncol 1991;4:21-7.
21. Heidecke CD, Weighardt H, Feith M, et al. Neoadjuvant treatment of esophageal cancer: immunosuppression following combined radiochemotherapy. Surgery 2002;132:495-501.
22. Nozoe T, Saeki H, Ohga T, Sugimachi K. Preoperative therapy with insufficient effectiveness is related to unfavorable prognosis of patients with esophageal squamous cell carcinoma. Oncol Rep 2001;8:1103-6.
23. Nozoe T, Miyazaki M, Saeki H, et al. Significance of allogenic blood transfusion on decreased survival in patients with esophageal carcinoma. Cancer 2001;92:1913-8.